WAYLON STEELE: Open Payments
NPI 1730627944 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,820 in 71 payments from 19 companies in 2025. Trend: 2023 $2,727 · 2024 $3,218 · 2025 $5,820
Speaker / faculty: $4,350Food & beverage: $1,456Education: $13
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 24 | $4,832 |
| Janssen Biotech, Inc. | 19 | $421 |
| GENZYME CORPORATION | 3 | $68 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $62 |
| Lilly USA, LLC | 3 | $54 |
| Arcutis Biotherapeutics, Inc. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| ABBVIE INC. | 2 | $45 |
| Botanix SB Inc | 2 | $44 |
| MERZ NORTH AMERICA, INC. | 1 | $27 |
Products named: NEMLUVIO, TREMFYA, DUPIXENT, TALTZ, Zoryve, COSENTYX, SOFDRA, NUZYRA.
Industry payments across PA — which companies pay providers there.
